IGM Biosciences, Inc. Operating Lease, Liability, Noncurrent
IGM Biosciences, Inc. had Operating Lease, Liability, Noncurrent of $0 as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-07-31
- 2025-06-30: Operating Lease, Liability, Noncurrent $0.00.
- 2025-03-31: Operating Lease, Liability, Noncurrent $36.94M.
- 2024-12-31: Operating Lease, Liability, Noncurrent $38.06M.
- 2024-09-30: Operating Lease, Liability, Noncurrent $39.16M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $36.94M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $38.06M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $39.16M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $33.44M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $34.30M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $34.67M 10-K · filed 2025-03-06 |
| 2023-09-30 | $34.98M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $34.54M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $34.87M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $35.36M 10-K · filed 2024-03-07 |
| 2022-09-30 | $23.73M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $24.85M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $25.85M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $25.44M 10-K · filed 2023-03-30 |
| 2021-09-30 | $26.20M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $9.15M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.05M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $9.58M 10-K · filed 2022-03-29 |
| 2020-09-30 | $10.26M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $10.93M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $11.60M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $12.24M 10-K · filed 2021-03-30 |
| 2019-09-30 | $8.81M 10-Q · filed 2019-11-07 |